AML-122 Midostaurin Maintenance versus Allo SCT versus W&W in FLT3-Mutated AML: A “Real-Life” Multicenter Study

Autor: de la Fuente, Adolfo 1, Beya, Marina Diaz 2, Beneit, Paola 3, Moreno, Ainhoa Fernandez 4, Sangerman, Montserrat Arnan 5, Garrido, Ana 6, Polo, Susana Vives 7, Fortes, Maria Garcia 8, Mayol, Antonia Sampol 9, Labrador, Jorge 10, Guinon, Antoni Garcia 11, Cortes, Cristina Gil 12, Bergua, Juan 13, Olave, Mayte 14, Amigo, Maria Luz 15, Ortin, Xavi 16, Vall-LLovera, Ferran 17, Estevez, Monica 1, Diaz-Lopez, Antonio 18, Serrano, Josefina 19, Tormo, Mar 20
Zdroj: In Clinical Lymphoma, Myeloma and Leukemia October 2022 22 Supplement 2:S215-S215
Databáze: ScienceDirect
Externí odkaz: